Everolimus

Everolimus ATC Code L01EG02 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mammalian target of rapamycin (mTOR) kinase inhibitors - Everolimus
Everolimus
RoutesOral
FDA Approval Date2009-03-30
Molecular FormulaC53H83NO14
Molecular Weight958.24 g/mol
CAS Number159351-69-6
Brand namesAfinitor, Zortress

Everolimus list of brand/trade names

    

    ATC Codes

    1. Alimentary tract and metabolisma
    2. Blood and blood forming organs
    3. Cardiovascular system
    4. Dermatological drugs
    5. Genitourinary system and reproductive hormones
    6. Systemic hormonal preparations, excluding reproductive hormones and insulins
    7. Antiinfectives for systemic use
    8. Antineoplastic and immunomodulating agents
    9. Musculoskeletal system
    10. Nervous system
    11. Antiparasitic products, insecticides and repellents
    12. Respiratory system
    13. Sensory organs
    14. Various ATC structures

    The newly added categories

    1. Tivozanib
    2. Fedratinib
    3. Tucatinib
    4. Everolimus
    5. Abemaciclib
    6. Selumetinib
    7. Gefitinib
    8. Minoxidil
    9. Diclofenac
    10. Mecillinam